Skip to main content


Table 3 Trial feasibility criteria as per the funder request

From: Platelet-rich plasma in Achilles tendon healing 2 (PATH-2) trial: statistical analysis plan for a multicentre, double-blinded, parallel-group, placebo-controlled randomised clinical trial

Criteria Target
Number of sites open to recruitment 7
Ratio of patients consented/eligible ≥ 20%
Number of participants randomised ≥ 50
Compliance with intervention Subjective, percentage of non-compliers to be considered
Loss to follow-up ≤ 30%
Safety Subjective, all adverse events and serious adverse events considered